All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...703Next →

hiv & aids news selected from other sources

  • Hepatitis C treatment
    Britain Has No Problem Paying for Expensive Hepatitis C Drugs
    Businessweek | 19 August 2014

    The U.K.’s decision to recommend Sovaldi was far from a sure thing. But once the National Institute for Health and Care Excellence was convinced that Sovaldi is cost-effective, the decision to pay for it is simple, because one entity pays for all the medical care in the U.K. If treating a patient with costly drugs now prevents a more expensive liver transplant in 15 years, that savings accrues to the National Health Service—and ultimately to British taxpayers.

  • Retention and linkage to care
    PEPFAR’s South Africa “transition”: Nearly 20 percent of patients went unaccounted for when care was transferred, study finds
    Science Speaks | 19 August 2014

    Survey finding gaps in care, records during transfer of patients from PEPFAR-supported program to community-based clinics comes as new report cites need for data.

  • Medical procedures and other blood-borne exposure
    From HIV to Ebola: How to protect health workers in West Africa
    Devex | 19 August 2014

    What can we learn from the global response to HIV and AIDS that can be applied now to aid workers dealing with the Ebola outbreak in West Africa? Mead Over, a senior fellow at the Center for Global Development, urges donors to help affected governments protect health workers in Ebola-affected areas.

  • Epidemiology and behaviour
    Teen Anal Sex Study: 6 Unexpected Findings
    Live Science | 18 August 2014

    Anal sex can hurt, that much seems clear. But a new study of British teenagers also reveals a few aspects of this sexual activity that are perhaps more surprising.

  • Discrimination and the law
    Passengers with HIV sue China's Spring Airlines
    BBC News | 18 August 2014

    Two passengers with HIV are suing a budget Chinese airline for refusing to let them board a plane. Local media reports say the two men and a friend - who does not have HIV - were prevented from boarding a Spring Airlines plane at Shenyang airport.

  • New and experimental hepatitis C treatment
    PegLambda discontinued by BMS
    EATG | 18 August 2014

    We have concluded that given the very promising developments in HCV in terms of emerging all-oral therapeutic options, Lambda would no longer fulfill the unmet need that we had envisioned upon initiation of the clinical trials.

  • New and experimental hepatitis C treatment
    Achillion Achieves 100 Percent Sustained Virologic Response Rate (SVR4) From an Eight Week Phase 2 Trial Evaluating a Ribavirin-Free Regimen of ACH-3102 and Sofosbuvir for Genotype 1 HCV ("Proxy Study")
    Achillion press release | 18 August 2014

    Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced interim results from an ongoing Phase 2 proxy study evaluating ACH-3102, Achillion's second-generation NS5A inhibitor, in combination with sofosbuvir, without ribavirin, for eight weeks of treatment in patients with treatment-naïve genotype 1 chronic hepatitis C virus (HCV) infection.

  • The search for a cure
    'Shock and kill' approach cures mice of HIV in world first
    The Conversation | 18 August 2014

    A combination of four drugs can flush out HIV-infected cells from hidden reservoirs in the body and kill them with a boost to the immune system, according to research published in the journal Cell today.

  • Hepatitis C treatment
    NICE consults on further draft guidance on the drug sofosbuvir (Sovaldi) for treating hepatitis C
    NICE | 15 August 2014

    In further draft guidance NICE has recommended sofosbuvir (Sovaldi, Gilead Sciences) as a treatment option for some people with chronic hepatitis C. The positive recommendation follows receipt of additional information about the drug’s cost effectiveness from the manufacturer.

  • Hepatitis C treatment
    UK cost body backs pricey Gilead hepatitis pill for some patients
    Reuters | 15 August 2014

    Carole Longson, director of the NICE Centre for Health Technology Evaluation, said on Friday it was now provisionally recommending Sovaldi, also known as sofosbuvir, as a cost-effective treatment for some people with chronic hepatitis C.

← First12345...927Next →

Hepatitis C news

WHO recommends global use of newest hepatitis C drugs, urges price reductions.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.